0001357019-13-000002.txt : 20131024 0001357019-13-000002.hdr.sgml : 20131024 20131024164048 ACCESSION NUMBER: 0001357019-13-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20131024 DATE AS OF CHANGE: 20131024 EFFECTIVENESS DATE: 20131024 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PLUROGEN THERAPEUTICS INC CENTRAL INDEX KEY: 0001357019 IRS NUMBER: 203893334 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-205217 FILM NUMBER: 131168545 BUSINESS ADDRESS: STREET 1: 2495 GENERAL ARMISTEAD AVENUE CITY: NORRISTOWN STATE: PA ZIP: 19403 BUSINESS PHONE: 6105393670 MAIL ADDRESS: STREET 1: 2495 GENERAL ARMISTEAD AVENUE CITY: NORRISTOWN STATE: PA ZIP: 19403 D 1 primary_doc.xml X0707 D LIVE 0001357019 PLUROGEN THERAPEUTICS INC 2495 GENERAL ARMISTEAD AVENUE NORRISTOWN PA PENNSYLVANIA 19403 6105393670 DELAWARE PluroGen Therapeutics, LLC None Corporation true Neal G. Koller 3724A Thomas Point Road Annapolis MD MARYLAND 21403 Executive Officer Director George T. Rodeheaver 845 Carlins Way Charlottesville VA VIRGINIA 22903 Executive Officer Director Adam J. Katz 3131 SW 98 Drive Gainesville FL FLORIDA 32608 Executive Officer Director James B. Farinholt, Jr. Westham Green #7 300 North Ridge Road Richmond VA VIRGINIA 23229 Director Daniel Brody 503 Faulconer Drive Charlottesville VA VIRGINIA 22903 Director Wendy L. Yarno 60 Simmons Lane Sedona AZ ARIZONA 86531 Director Biotechnology Decline to Disclose 06b false 2013-10-10 false true true The offering consists of convertible promissory notes to acquire Series C shares and warrants to acquire Series C shares. false 50000 3500000 75000 3425000 The Board, in its discretion, can authorize a minimum investment of less than $50,000. false 2 0 0 400000 true false PLUROGEN THERAPEUTICS INC /Neal G. Koller/ Neal G. Koller President and CEO 2013-10-24